BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 15998678)

  • 1. Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection.
    El-Sawy T; Belperio JA; Strieter RM; Remick DG; Fairchild RL
    Circulation; 2005 Jul; 112(3):320-31. PubMed ID: 15998678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
    van der Touw W; Burrell B; Lal G; Bromberg JS
    Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis.
    El-Sawy T; Miura M; Fairchild R
    Am J Pathol; 2004 Jul; 165(1):147-57. PubMed ID: 15215170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
    Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
    Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
    Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
    J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
    Hancock WW; Sayegh MH; Zheng XG; Peach R; Linsley PS; Turka LA
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13967-72. PubMed ID: 8943044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement Dependence of Murine Costimulatory Blockade-Resistant Cellular Cardiac Allograft Rejection.
    Chun N; Fairchild RL; Li Y; Liu J; Zhang M; Baldwin WM; Heeger PS
    Am J Transplant; 2017 Nov; 17(11):2810-2819. PubMed ID: 28444847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
    Sayegh MH; Zheng XG; Magee C; Hancock WW; Turka LA
    Transplantation; 1997 Dec; 64(12):1646-50. PubMed ID: 9422396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients.
    Wu Z; Wang Y; Gao F; Shen X; Zhai Y; Kupiec-Weglinski JW
    J Immunol; 2008 Jul; 181(2):1096-102. PubMed ID: 18606661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.
    Bartlett AS; McCall JL; Ameratunga R; Howden B; Yeong ML; Benjamin CD; Hess D; Peach R; Munn SR
    Liver Transpl; 2002 May; 8(5):458-68. PubMed ID: 12004346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.
    Shimizu K; Libby P; Rocha VZ; Folco EJ; Shubiki R; Grabie N; Jang S; Lichtman AH; Shimizu A; Hogg N; Simon DI; Mitchell RN; Croce K
    Circulation; 2011 Dec; 124(25):2920-32. PubMed ID: 22144572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte integrin Mac-1 promotes acute cardiac allograft rejection.
    Shimizu K; Libby P; Shubiki R; Sakuma M; Wang Y; Asano K; Mitchell RN; Simon DI
    Circulation; 2008 Apr; 117(15):1997-2008. PubMed ID: 18378617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloreactive CD8 T-cell primed/memory responses and accelerated graft rejection in B-cell-deficient sensitized mice.
    Ji H; Shen XD; Gao F; Busuttil RW; Zhai Y; Kupiec-Weglinski JW
    Transplantation; 2011 May; 91(10):1075-81. PubMed ID: 21427633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice.
    Xie B; Chen J; Wang F; Lan T; Wang Y; Xia J; Li Z; Xie Q; Huang R; Qi Z
    Scand J Immunol; 2010 May; 71(5):345-52. PubMed ID: 20500685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.